Download CANTEL MEDICAL CORP.

CANTEL MEDICAL CORP.
150 Clove Road
Little Falls, New Jersey 07424
FOR IMMEDIATE RELEASE
Contact: Andrew A. Krakauer
President and CEO
Cantel Medical Corp.
Phone: (973) 890-7220
Richard E. Moyer
Cameron Associates, Inc.
[email protected]
Phone: (212) 554-5466
CANTEL MEDICAL’S MINNTECH SUBSIDIARY NAMED
FINALIST FOR 2011 TEKNE AWARDS
LITTLE FALLS, N.J. – October 3, 2011 - CANTEL MEDICAL CORP.’s (NYSE:CMN)
Minneapolis, MN based subsidiary, Minntech Corporation, has been named by the
Minnesota High Tech Association (MHTA), as one of three finalists in the Life Sciences
Award - Established Companies Category for the 2011 Tekne Awards. The Tekne
Awards recognize Minnesota companies and individuals who have shown superior
technology innovation and leadership. The awards ceremony will be held at the
Minneapolis Convention Center on Thursday, November 3, 2011.
Minntech was honored as a finalist from among the top tech-based companies in
Minnesota for its latest advancement in innovation and product sterilization technology:
REVOXSM Contract Sterilization Services. Developed by Cantel Infection Prevention and
Control Chemistries (IPCC), a new business unit formed at Minntech in 2010, the
REVOX service is the only rapid turnaround, true room-temperature vapor sterilization
(18 – 30°C) offering for the medical, pharmaceutical and consumer products industries.
The technology allows heat-sensitive devices to be sterilized without compromising
materials compatibility, product quality or integrity, and also significantly reduces the
preparation time of the sterilization process that is associated with other methods.
"We are excited to be named as a finalist for the Tekne Award and be recognized for our
innovation,” said Andrew Krakauer, President and CEO, Cantel Medical Corp.
“Minntech’s recent technological advancements in the sterilization arena, combined with
outstanding customer support, have provided significant value to our customers. We will
continue to provide new and innovative products and services to infection prevention and
control markets."
Presented by the MHTA, the Tekne Awards annually recognize Minnesota’s best and
brightest technology users and developers in innovation, development, education,
commercialization and management. A full list of finalists is available online at
http://www.tekneawards.org.
2
About Cantel Infection Prevention & Control Chemistries (IPCC)
Cantel IPCC is a Business Group of Minntech Corporation, a subsidiary of Cantel
Medical Corp. IPCC delivers infection prevention solutions for healthcare, consumer,
pharmaceutical and industry customers through proprietary chemistries and innovative
equipment and services. For more information, visit www.minntech.com
About Cantel Medical Corp.
Cantel Medical Corp. (NYSE:CMN) is a leading provider of infection prevention and
control products in the healthcare market. Our products include water purification
equipment, sterilants, disinfectants and cleaners, specialized medical device reprocessing
systems for endoscopy and renal dialysis, disposable infection control products primarily
for the dental industry, dialysate concentrates and other dialysis supplies, hollow fiber
membrane filtration and separation products for medical and non-medical applications,
and specialty packaging for infectious and biological specimens. We also provide
technical maintenance for our products and offer compliance training services for the
transport of infectious and biological specimens. For further information, visit the Cantel
website at www.cantelmedical.com
This press release contains forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These statements involve a number of risks and
uncertainties, including, without limitation, the risks detailed in Cantel's filings and
reports with the Securities and Exchange Commission. Such forward-looking statements
are only predictions, and actual events or results may differ materially from those
projected or anticipated.